Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2026 for Phio Pharmaceuticals Corp..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Curtis Lockshin: trading record in brief
Curtis Lockshin (board member) discloses dealings in Phio Pharmaceuticals Corp. to SEC (Form 4). We count 8 filings; the first trade dates from 1 August 2018 and the latest from 5 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 6 February 2026, the filings show a share grant in Phio Pharmaceuticals Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Curtis Lockshin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
16,600 shares0Common Stock, $.0001 par valueSEC:0001683168-26-000813:0
16,200 shares0Common Stock, $.0001 par valueSEC:0001683168-25-006959:0
2,000 shares0Common Stock, $0.0001 par valueSEC:0001683168-24-006336:0
1,500 shares0Common stock, $0.0001 par valueSEC:0001209191-23-011942:0
10,000 shares0Common stock, $0.0001 par valueSEC:0001209191-22-010405:0
5 of 5 declarations
